These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Phosphodiesterase inhibitors in female sexual dysfunction. Mayer M, Stief CG, Truss MC, Uckert S. World J Urol; 2005 Dec; 23(6):393-7. PubMed ID: 16247643 [Abstract] [Full Text] [Related]
25. Phosphodiesterase isoenzymes in the human urethra: a molecular biology and functional study. Kedia GT, Oelke M, Sonnenberg JE, Sohn M, Bannowsky A, Kuczyk MA, Ückert S. Eur J Pharmacol; 2014 Oct 15; 741():330-5. PubMed ID: 25160741 [Abstract] [Full Text] [Related]
26. Formalin injection causes a coordinated spinal cord CO/NO-cGMP signaling system response. Shi X, Li X, Clark JD. Mol Pain; 2005 Nov 18; 1():33. PubMed ID: 16297238 [Abstract] [Full Text] [Related]
28. Lower urinary tract symptoms/benign prostatic hypertrophy and vascular function: Role of the nitric oxide-phosphodiesterase type 5-cyclic guanosine 3',5'-monophosphate pathway. Higashi Y. Int J Urol; 2017 Jun 18; 24(6):412-424. PubMed ID: 28332240 [Abstract] [Full Text] [Related]
36. Nitric oxide signaling pathways in the normal and pathological bladder: Do they provide new pharmacological pathways?-ICI-RS 2023. Chakrabarty B, Winder M, Kanai AJ, Hashitani H, Drake M, Abrams P, Fry CH. Neurourol Urodyn; 2024 Aug 24; 43(6):1344-1352. PubMed ID: 37902298 [Abstract] [Full Text] [Related]
38. Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats. Morelli A, Sarchielli E, Comeglio P, Filippi S, Mancina R, Gacci M, Vignozzi L, Carini M, Vannelli GB, Maggi M. J Sex Med; 2011 Oct 24; 8(10):2746-60. PubMed ID: 21812935 [Abstract] [Full Text] [Related]